2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
3
Vulvar Neoplasms
2
Melanoma
2
Liver Metastases
2
Ulcer
1
Skin Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Pathologic Processes
1
Pancreatic Neoplasms
1
Neoplastic Processes
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma, Cutaneous Malignant
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Gynecological Cancers
1
Desmoid Tumors
1
Colorectal Neoplasms
1
Breast Cancer Female
1
Interventions
pembrolizumab
185
Gemcitabine
170
Paclitaxel
152
Carboplatin
137
Bevacizumab
128
Surveys and Questionnaires
118
Cisplatin
115
Docetaxel
114
Blood Specimen Collection
110
Cyclophosphamide
109
Exercise
108
Nivolumab
99
Fluorouracil
90
Capecitabine
86
Radiotherapy
81
Dexamethasone
81
Irinotecan
74
Standard of Care
69
Pemetrexed
68
Oxaliplatin
68
Drug Therapy
65
Leucovorin
64
Cetuximab
60
Erlotinib Hydrochloride
56
atezolizumab
53
Sorafenib
53
Ipilimumab
51
Doxorubicin
50
trametinib
47
Interviews as Topic
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Electrochemotherapy
×
Clear all
NCT03040180
2019-01-25
nECT
Zealand University Hospital
Phase 2
Unknown
40 enrolled